CPT code 83615 – Lactate dehydrogenase measurement

Key takeaways

CPT Code 83615 covers total LDH measurement only, and isoenzyme fractionation is billed separately under CPT 83625.

LDH is not a component of the AMA-defined CMP (80053) or BMP (80048), but some payers apply their own bundling rules.

Medicare pays 83615 under the Clinical Laboratory Fee Schedule (CLFS), not the Physician Fee Schedule, and rates vary by MAC jurisdiction.

R74.02 codes an elevated LDH result directly, so it supports follow-up LDH testing better than the catch-all R79.89.

Practice management software like Pabau generates claims from your invoices and runs validation checks before they reach the payer.

CPT Code 83615: Official descriptor and procedure overview

CPT Code 83615 is the code for a quantitative test of total lactate dehydrogenase activity in serum or plasma. Its official American Medical Association descriptor is Lactate dehydrogenase (LD), (LDH). It falls within the Chemistry Procedures section of the CPT code set (codes 82009 through 84999).

That section covers single-analyte quantitative measurements on serum, plasma, or whole blood. The test produces one numeric result, and Medicare pays for it under the Clinical Laboratory Fee Schedule.

LDH is an intracellular enzyme present in most tissues. When cells are damaged or destroyed, LDH leaks into the bloodstream. A total LDH result shows that cell damage has occurred somewhere, but not which tissue is involved. That question is answered by 83625, the isoenzyme fractionation code, not by 83615 itself.

Clinical indications: When is an LDH test ordered?

Medical necessity for CPT Code 83615 exists when the ordering clinician documents a condition linked to tissue damage, abnormal cell proliferation, or hemolysis. These are the indications payer policies accept most often.

• Lymphoma and hematologic malignancies: LDH is a prognostic marker in non-Hodgkin and Hodgkin lymphoma. Elevated levels track tumor burden and guide staging decisions.
• Hepatic disease: Elevated LDH accompanies hepatitis, cirrhosis, and hepatocellular injury. It’s often ordered alongside ALT, AST, and alkaline phosphatase.
• Myocardial infarction: LDH was historically used for MI diagnosis. Troponin has largely replaced it, but 83615 is still ordered in delayed presentations after troponin has normalized.
• Hemolytic anemia: Intravascular hemolysis causes a marked rise in serum LDH. The test helps separate hemolytic anemia from other anemia types.
• Pulmonary embolism: LDH may rise with right heart strain and pulmonary infarction. It’s used alongside D-dimer and troponin in the PE workup.
• Cancer treatment monitoring: LDH is tracked serially in solid tumor management, such as melanoma and testicular cancer. It serves as an indirect measure of disease activity and treatment response.
• Muscle injury: Rhabdomyolysis and severe muscle trauma raise serum LDH. It’s used alongside CK (CPT 82550) in the trauma workup.

The ordering note should name the working diagnosis that makes each test necessary. A note that records symptoms without a working diagnosis frequently triggers medical necessity denials.

ICD-10 codes that support medical necessity for 83615

Pairing CPT Code 83615 with a well-supported ICD-10 diagnosis code is the most effective way to prevent payer denials. The CDC ICD-10-CM tool maintains the complete list of valid diagnosis codes. The table below covers the pairings commercial and Medicare payers accept most often.

Use the most specific code available. When the finding is a raised LDH, R74.02 names it directly, so there’s no need to fall back on R79.89. Claims billed with only an “other abnormal” code and no clinical diagnosis face higher audit risk.

Payers that follow Local Coverage Determinations (LCDs) for lab tests usually require the ordering diagnosis to appear on the LCD’s covered-diagnoses list.

CPT 83615 vs CPT 83625: Total LDH vs isoenzymes

CPT 83615 measures total LDH activity in a single enzymatic reaction. CPT 83625 separates LDH into its five isoenzyme fractions (LDH-1 through LDH-5), usually by electrophoresis. That shows clinicians which tissue source is driving the elevation.

The most common coding error here is ordering both tests at once and billing both codes on the same claim. When isoenzymes are run only after an elevated total LDH, the two tests usually fall on different dates of service. Each one can then be billed separately.

Same-day dual billing triggers automatic payer edits and is a leading denial cause for this code pair. The panel below maps each ordering scenario to the code that belongs on the claim.

Medicare reimbursement for 83615 (2025-2026)

Medicare pays for CPT Code 83615 under the Clinical Laboratory Fee Schedule (CLFS), not the Physician Fee Schedule. The Centers for Medicare and Medicaid Services (CMS) updates the CLFS every year. It sets maximum payments for lab tests billed by independent labs, hospital outpatient labs, and physician office labs.

The CMS Physician Fee Schedule search tool doesn’t apply to 83615. The test has no professional component, so it’s technical-only.

Reimbursement for 83615 is modest. Under the 2025 CLFS, national limitation amounts for simple chemistry tests in this range typically fall between $5 and $15. The exact figure for 83615 varies by MAC jurisdiction and appears in the annual CMS CLFS rate file.

Pull your MAC’s current CLFS schedule directly rather than relying on third-party fee data, which can lag the effective date.

Payer coverage policies and prior authorization requirements

CPT Code 83615 generally doesn’t need prior authorization. Medical necessity must still be documented under the Local Coverage Determination (LCD) or National Coverage Determination (NCD) that applies in the ordering clinician’s MAC jurisdiction.

Key payer policy points for 83615:

• Medicare LCD coverage: Medicare Administrative Contractors issue LCDs for lab testing that list covered ICD-10 codes. If the ordering diagnosis isn’t on the covered list, the lab must issue an Advance Beneficiary Notice of Noncoverage (ABN) before drawing the specimen. An ABN lets the patient choose to pay out of pocket if Medicare denies the claim.
• Commercial payer bundling: LDH is NOT a component analyte of the AMA-defined metabolic panels, 80053 and 80048. Some commercial payers apply their own bundling edits that fold LDH into proprietary panel definitions. Check your payer contracts before assuming 83615 is separately billable alongside either panel.
• Standalone LDH denials: Several commercial payers deny 83615 when it’s billed without a diagnosis consistent with the clinical indications above. A generic follow-up or wellness diagnosis code rarely establishes medical necessity for an LDH test.

Documentation requirements for LDH claims

A complete ordering note for CPT Code 83615 needs specific elements to survive payer review and any later audit. Missing even one element is grounds for a post-payment recoupment request.

• Clinical indication: The note must state why LDH testing is clinically warranted for this encounter. Tie it to symptoms, a working diagnosis, or a treatment monitoring plan.
• Ordering provider credentials: The ordering clinician must be enrolled with the payer. Unenrolled providers generate automatic claim rejections unrelated to the test itself.
• Specimen type and collection: Record the specimen type (serum or plasma), collection date, and collection time. For time-sensitive workups, those timestamps establish the clinical context for repeat testing with modifier 91.
• Linking diagnosis: The ICD-10 code on the claim must appear in the encounter note. A code submitted on the claim but absent from the note is a documentation mismatch that invites audit.
• Lab report linkage: The lab report must link back to the ordering provider’s note. When the practice sends blood to a reference lab such as Quest Diagnostics, it keeps responsibility for documentation completeness.

Capturing these elements when the test is ordered is far easier than rebuilding them after a payer requests records.

Common denial reasons for CPT Code 83615 and how to avoid them

Denials for CPT Code 83615 cluster around five predictable root causes. When a remittance comes back, match its reason code against our list of denial codes for billers to find the fix.

Billing teams working in claims software for practices with built-in CPT and ICD-10 catalogs can run pre-submission edits. Those edits catch the first three denial types before a claim reaches the clearinghouse.

Modifiers used with 83615

Most 83615 claims go out without modifiers. Three scenarios call for one.

• Modifier 91 (repeat clinical diagnostic laboratory test): Apply it to a same-day repeat for a new clinical episode or a time-course evaluation. Don’t use it to rebill a test repeated because of a lab error or quality failure. CMS and most commercial payers deny those repeats.
• Modifier 59 (distinct procedural service): Use it when 83615 is denied as bundled with a panel but was a medically distinct service. Modifier 59 requires documentation that the LDH was ordered for an indication separate from the panel’s component tests.
• Modifier QW (CLIA-waived test): It applies in point-of-care settings with a CLIA Certificate of Waiver, when the LDH test method has waived status. Verify the specific test system’s CLIA status before applying QW, because not all LDH assays are waived.

Hospital outpatient departments bill 83615 under the hospital’s outpatient provider number with the relevant place-of-service code. That setting decides which fee schedule applies and how the facility’s bundled payment treats the test. Build setting-specific rules into your billing workflow when one code is billed in both outpatient and office settings.

How practice management software streamlines LDH test billing

Most 83615 errors start between the lab order and the submitted claim. A biller who looks a code up in one system and retypes it into another adds transcription risk at every step.

Practice management software like Pabau generates claims from the invoices your team already raises, with the invoice details pre-filled. Through Claim.MD, our US clearinghouse integration, claims go electronically to thousands of payers. Real-time eligibility checks confirm the patient’s coverage before the specimen is drawn.

Pabau also runs validation checks in the background for required details such as membership numbers and authorization codes. Each claim’s status then updates in one dashboard, from submission to payment or denial. Electronic remittance advice posts back against the right invoice, so a denied 83615 claim shows up the day it returns.

Insurer-specific price lists let you set your contracted fee for 83615 per payer. A short payment then stands out against the rate you agreed, instead of hiding in a spreadsheet.

Stop chasing denied lab claims

Pabau turns your invoices into claims, checks eligibility in real time, and tracks every CPT Code 83615 claim from submission to payment.

Book a demo

Conclusion

Most 83615 denials are preventable, and they come from two decisions made before the claim exists. Decide up front when isoenzymes are needed, then keep 83625 off the date the total LDH was billed.

Next, check each commercial contract for proprietary panel bundling before billing 83615 alongside 80053 or 80048. A few minutes of setup per payer costs less than working the same denial every month.

The fee on this code is small, so it only pays when it’s collected on the first pass. Book a demo to see how Pabau tracks lab claims from invoice to payment.

Continue your research

Need to understand how clearinghouse edits work before claims reach the payer? How medical claims clearinghouses process lab claims explains the real-time edit checks that catch CPT and ICD-10 mismatches at submission.

Working a backlog of denied lab claims? Denial management in healthcare covers the workflow for categorizing, appealing, and preventing recurring denials by root cause.

Building out a lab billing compliance program? Medical billing compliance sets out the documentation and audit standards that apply to chemistry panel claims, including 83615.

Frequently asked questions